482 related articles for article (PubMed ID: 16125076)
61. Up-regulation of MyD88s and SIGIRR, molecules inhibiting Toll-like receptor signaling, in monocytes from septic patients.
Adib-Conquy M; Adrie C; Fitting C; Gattolliat O; Beyaert R; Cavaillon JM
Crit Care Med; 2006 Sep; 34(9):2377-85. PubMed ID: 16850005
[TBL] [Abstract][Full Text] [Related]
62. Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis.
Huang Q; Ma Y; Adebayo A; Pope RM
Arthritis Rheum; 2007 Jul; 56(7):2192-201. PubMed ID: 17599732
[TBL] [Abstract][Full Text] [Related]
63. A food-born heterocyclic amine, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), suppresses tumor necrosis factor-alpha expression in lipoteichoic acid-stimulated RAW 264.7 cells.
Im J; Choi HS; Kim SK; Woo SS; Ryu YH; Kang SS; Yun CH; Han SH
Cancer Lett; 2009 Feb; 274(1):109-17. PubMed ID: 18845389
[TBL] [Abstract][Full Text] [Related]
64. Multiplexed cytokine detection in microliter microdialysis samples obtained from activated cultured macrophages.
Ao X; Wang X; Lennartz MR; Loegering DJ; Stenken JA
J Pharm Biomed Anal; 2006 Mar; 40(4):915-21. PubMed ID: 16242281
[TBL] [Abstract][Full Text] [Related]
65. Macrophage recognition of zymosan particles.
Underhill DM
J Endotoxin Res; 2003; 9(3):176-80. PubMed ID: 12831459
[TBL] [Abstract][Full Text] [Related]
66. Interaction of lipoteichoic acid and CpG-DNA during activation of innate immune cells.
Dalpke AH; Frey M; Morath S; Hartung T; Heeg K
Immunobiology; 2002 Oct; 206(4):392-407. PubMed ID: 12437070
[TBL] [Abstract][Full Text] [Related]
67. Negative regulatory role of mannose receptors on human alveolar macrophage proinflammatory cytokine release in vitro.
Zhang J; Tachado SD; Patel N; Zhu J; Imrich A; Manfruelli P; Cushion M; Kinane TB; Koziel H
J Leukoc Biol; 2005 Sep; 78(3):665-74. PubMed ID: 16000387
[TBL] [Abstract][Full Text] [Related]
68. Anaplasma phagocytophilum ligation to toll-like receptor (TLR) 2, but not to TLR4, activates macrophages for nuclear factor-kappa B nuclear translocation.
Choi KS; Scorpio DG; Dumler JS
J Infect Dis; 2004 May; 189(10):1921-5. PubMed ID: 15122530
[TBL] [Abstract][Full Text] [Related]
69. Induction of tumor necrosis factor- alpha secretion and toll-like receptor 2 and 4 mRNA expression by genital mucosal fluids from women with bacterial vaginosis.
Zariffard MR; Novak RM; Lurain N; Sha BE; Graham P; Spear GT
J Infect Dis; 2005 Jun; 191(11):1913-21. PubMed ID: 15871126
[TBL] [Abstract][Full Text] [Related]
70. Up-regulation of CD80-CD86 and IgA on mouse peritoneal B-1 cells by porin of Shigella dysenteriae is Toll-like receptors 2 and 6 dependent.
Ray A; Karmakar P; Biswas T
Mol Immunol; 2004 Nov; 41(12):1167-75. PubMed ID: 15482852
[TBL] [Abstract][Full Text] [Related]
71. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling.
Wald D; Qin J; Zhao Z; Qian Y; Naramura M; Tian L; Towne J; Sims JE; Stark GR; Li X
Nat Immunol; 2003 Sep; 4(9):920-7. PubMed ID: 12925853
[TBL] [Abstract][Full Text] [Related]
72. Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state.
Broering R; Montag M; Jiang M; Lu M; Sowa JP; Kleinehr K; Gerken G; Schlaak JF
Int Immunol; 2011 Sep; 23(9):537-44. PubMed ID: 21750146
[TBL] [Abstract][Full Text] [Related]
73. Macrophage tumor necrosis factor-alpha release is induced by contact with some tumors.
Hasday JD; Shah EM; Lieberman AP
J Immunol; 1990 Jul; 145(1):371-9. PubMed ID: 2358679
[TBL] [Abstract][Full Text] [Related]
74. Deficient tumor necrosis factor-alpha production in lipoarabinomannan activated macrophages from toll-like receptor-4 deficient mice: implication for mycobacterial susceptibility.
Levis W; Schuller-Levis GB; Park E
Int J Lepr Other Mycobact Dis; 2003 Mar; 71(1):1-9. PubMed ID: 12914127
[TBL] [Abstract][Full Text] [Related]
75. Investigating the function of a novel protein from Anoectochilus formosanus which induced macrophage differentiation through TLR4-mediated NF-κB activation.
Kuan YC; Lee WT; Hung CL; Yang C; Sheu F
Int Immunopharmacol; 2012 Sep; 14(1):114-20. PubMed ID: 22749731
[TBL] [Abstract][Full Text] [Related]
76. Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes.
Meng G; Rutz M; Schiemann M; Metzger J; Grabiec A; Schwandner R; Luppa PB; Ebel F; Busch DH; Bauer S; Wagner H; Kirschning CJ
J Clin Invest; 2004 May; 113(10):1473-81. PubMed ID: 15146245
[TBL] [Abstract][Full Text] [Related]
77. 1'S-1'-Acetoxychavicol acetate as a new type inhibitor of interferon-beta production in lipopolysaccharide-activated mouse peritoneal macrophages.
Ando S; Matsuda H; Morikawa T; Yoshikawa M
Bioorg Med Chem; 2005 May; 13(9):3289-94. PubMed ID: 15809164
[TBL] [Abstract][Full Text] [Related]
78. [Down-regulation of Toll-like receptor 4 is related to the tolerance to lipopolysaccharide in rat alveolar macrophages].
Zhang DM; Li YW; Mao BL; Qian GS
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jul; 26(7):411-4. PubMed ID: 12921646
[TBL] [Abstract][Full Text] [Related]
79. Role of innate immune response in liver regeneration.
Iimuro Y; Seki E; Son G; Tsutsui H; Nakanishi K; Fujimoto J
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S57-8. PubMed ID: 17567467
[TBL] [Abstract][Full Text] [Related]
80. Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices.
Birks EJ; Felkin LE; Banner NR; Khaghani A; Barton PJ; Yacoub MH
J Heart Lung Transplant; 2004 Feb; 23(2):228-35. PubMed ID: 14761771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
